Novobiocin Sodium (NSC 2382)

For research use only.

Catalog No.S2492 Synonyms: Albamycin, Cathomycin

4 publications

Novobiocin Sodium (NSC 2382) Chemical Structure

CAS No. 1476-53-5

Novobiocin Sodium (NSC 2382, Albamycin, Cathomycin) is an aminocoumarin antibiotic that targets bacterial DNA gyrase (TopoIV), used to treat susceptible gram positive bacteria.

Selleck's Novobiocin Sodium (NSC 2382) has been cited by 4 publications

1 Customer Review

  • Cell viability and caspase 3/7 activity in MDA-MB-231 cells co-treated with carbenoxolone, novobiocin, ibrutinib and bisphosphonates. Cell viability (A) and caspase 3/7 activity (B) was determined after treatment with ZA (zoledronic acid), RIS (risedronate), IBN (ibandronate), ALN (alendronate) in combination with carbenoxolone, novobiocin and ibrutinib. All data are expressed as means of three different measure points of three independent experiments ± SEM and were normalized to BP treatment alone. Significances were calculated with the Mann Whitney U test (*p < 0.05; **p < 0.005).

    Mol Cancer, 2014, 13(1):265.. Novobiocin Sodium (NSC 2382) purchased from Selleck.

Purity & Quality Control

Choose Selective Antineoplastic and Immunosuppressive Antibiotics Inhibitors

Biological Activity

Description Novobiocin Sodium (NSC 2382, Albamycin, Cathomycin) is an aminocoumarin antibiotic that targets bacterial DNA gyrase (TopoIV), used to treat susceptible gram positive bacteria.
Targets
Topoisomerase II [1] Topoisomerase IV [1]
In vitro

Novobiocin also interacts with Hsp90, altering the affinity of the chaperone for geldanamycin and radicicol and causing in vitro and in vivo depletion of key regulatory Hsp90-dependent kinases including v-Src, Raf-1, and p185(ErbB2). Novobiocin interferes with association of the co-chaperones Hsc70 and p23 with Hsp90. [1] Novobiocin specifically inhibits the maturation of the heme-regulated eIF2alpha kinase (HRI) in a concentration-dependent manner. Novobiocin induces the dissociation of Hsp90 and Cdc37 from immature HRI, while the Hsp90 cochaperones p23, FKBP52, and protein phosphatase 5 remained associated with immature HRI. [2] Novobiocin causes morphological and biochemical changes which lead to induction of cell death exhibiting characteristic features of metazoan apoptosis. [3] Novobiocin, a HSP90 inhibitor, could decrease the expression of SMYD3 and dose dependently inhibit the proliferation and migration of MDA-MB-231 human breast cancer cells. Novobiocin can inhibit the migration of breast cancer cells and such event may involve the downregulation of SMYD3. [4] Novobiocin, an aminocoumarin antibiotic, interferes with heat shock protein 90 and hypoxia inducible factor dependent gene expression and thus compromises cell survival. Novobiocin (500 礛) results in a significant increase of [Ca(2+)]i, decrease of forward scatter, increase of annexin-V-binding and enhances ceramide formation. Novobiocin stimulates eryptosis, an effect at least in part due to entry of extracellular Ca(2+) and formation of ceramide. [5]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
MCF7-MX M2HT[mZ2dmO2aX;uJIF{e2G7 NHjwbopVWF:WUlHOV3BQWlSHUkqgbY5pcWKrdHnvckBw\iCvaYTvfIFvfHKxbnWg[YZndHW6IHnuJGJEWlBvZYjwdoV{e2mwZzDNR2Y4NU2[IHPlcIx{NCCLQ{WwQVI2|ryP NG\Ub289[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNkS2NFc6QCd-MU[0OlA4QTh:L3G+
MELN M1TvOGZ2dmO2aX;uJIF{e2G7 MYqyNFAhfU1? MUWxPEBpenN? MWDJcohq[mm2aX;uJI9nKGW|dILh[IlwdC2rbnT1Z4VlKEWULX3l[IlifGWmIITyZY5{[3KrcITpc44hcW5iTVXMUkBk\WyuczDifUBu\WG|dYLpcochdHWlaX\ldoF{\SCjY4Tpeol1gSCjdDCyNFAhfU1iYX\0[ZIhOThiaILz NI[3TYU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{m3PVI3Oyd-MUe5O|kzPjN:L3G+
SH-SY5Y NH7LdXdP\XW{b4Dyc5Rm[3Srb36gZZN{[Xl? MnTDUoV2em:ycn;0[YN1cW:wIHHnZYlve3RiYnX0ZU1idXmub3nkJJBmeHSrZHWgNU01Oi2rbnT1Z4VlKHSxeHnjbZR6KGmwIHj1cYFvKFOKLWPZOXkh[2WubIOgZZN{\XO|ZXSgZZMhdGGldHH0[UBl\Wi7ZILv[4Vv[XOnIILlcIVie2VuIFXDOVA:OC5yNEizPe69VQ>? MmjrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTlzM{i4OVkoRjF7MUO4PFU6RC:jPh?=
SH-SY5Y MkD2UoV2em:ycn;0[YN1cW:wIHHzd4F6 NWfmWXN[OTBibl2= MoPvUoV2em:ycn;0[YN1cW:wIHHnZYlve3RiYnX0ZU1idXmub3nkJJBmeHSrZHWgNU01Oi2rbnT1Z4VlKHSxeHnjbZR6KGmwIILleIlvd2mlIHHjbYQu\GmoZnXy[Y51cWG2ZXSgbJVu[W5iU1itV3k2YSClZXzsd{Bie3Onc4Pl[EBieyCuYXP0ZZRmKGSnaInkdo9o\W6jc3WgdoVt\WG|ZTDheEAyOCCwTR?= MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTF|OEi1PUc,OTlzM{i4OVk9N2F-
SH-SY5Y MXrO[ZVzd3C{b4TlZ5Rqd25iYYPzZZk> NGfncJBP\XW{b4Dyc5Rm[3Srb36gZYdicW6|dDDi[ZRiNWGveXzvbYQheGWydHnk[UAyNTR{LXnu[JVk\WRidH;4bYNqfHliaX6gdoV1cW6xaXOgZYNq\C2maX\m[ZJmdnSrYYTl[EBpfW2jbjDTTE1UYTW\IHPlcIx{KGG|c3Xzd4VlKGG|IHzhZ5RifGViZHXofYRzd2enbnHz[UBz\WynYYPl NVWwd29QRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUmxN|g5PTlpPkG5NVM5QDV7PD;hQi=>
LNCaP-LN3 MnjNRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? Mn3KRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCOTlPhVE1NVjNiY3XscJMtKEmFNUC9NU4xPc7:TR?= MkniQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFzMkm5PFIoRjJzMUK5PVgzRC:jPh?=
yeast PP30 MX7GeY5kfGmxbjDhd5NigQ>? M1nSUFExOCC3TR?= MYSzJIhzew>? NH3Tem9KdmirYnn0bY9vKG:oIHj1cYFvKEiVUEmwZYxxcGFiZYjwdoV{e2WmIHnuJJlm[XO2IGDQN|Ah[2WubIOgZ48u\XiycnXzd4lv\yCKU1[tcIFkYiC{ZYDvdpRmeiCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKGinYYSgd5Rz\XO|LXnu[JVk\WRicnXzdI9ve2ViYYSgNVAxKHWPIHHmeIVzKDNiaILz MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTF{OUm4Nkc,OjFzMkm5PFI9N2F-
Sf9 NXTsUWdHTnWwY4Tpc44h[XO|YYm= NV:wdIxnUW6qaXLpeIlwdiCxZjDFd4Np\XKrY3jpZUBkd2yrIFjpd|YufGGpZ3XkJHBiekNxUHHySUBmgHC{ZYPz[YQhcW5iYnHjeYxwfmm{dYOtbY5n\WO2ZXSgV4Y6KGOnbHzzJIJ6KGenbDDlcIVkfHKxcHjvdoV{cXNuIFnDOVA:OC5{Md88US=> NIrhb2Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUKzOVI1OSd-MkGyN|UzPDF:L3G+
SKBR3 MofSSpVv[3Srb36gZZN{[Xl? NYTGcplSOTByMDD1US=> NUThR|JQOThiaILz NU[ycGJZUW6qaXLpeIlwdiCxZjDIV3A6OCCrbjDoeY1idiCVS1LSN{Bk\WyuczDhd5Nme3OnZDDhd{Bi\2e{ZXfheIlwdiCxZjDpcpRz[WOnbHz1cIFzKEiHUkKgZZQhOTByMDD1UUBi\nSncjCxPEBpenNiYomgSGFRUSC|dHHpcolv\y2kYYPl[EBqdW23bn;mcJVwemW|Y3XuZ4UhdWmlcn;zZ49xcWNiYX7hcJl{cXN? NEnBTZQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{i1PVc4Pyd-MkO4OVk4Pzd:L3G+
BL21 (DE3) pLysS NWHYTWdITnWwY4Tpc44h[XO|YYm= NUXub|BlOTByIH3pcpM> NWnI[mlSUW6qaXLpeIlwdiCxZjC2MWhqey22YXfn[YQhVXmlb3LhZ5Rmemm3bTDzcYVodWG2aYOgS5lzSiCneIDy[ZN{\WRiaX6gSZNkcGW{aXPobYEh[2:uaTDCUFIyKCiGRUOpJJBNgXOVIHPlcIx{KGmwY4XiZZRm\CCob4KgNVAxKG2rboOgbY4heHKnc3XuZ4Uhd2ZiQWTQJIJ6KG2jbHHjbIl1\SCpcnXlckBlgWViYnHz[YQhSVSSIHHzd4F6NCCLQ{WwQVAvOTkQvF2= M1uwS|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUK5NVcyLz5{NUGyPVE4OTxxYU6=
BL21 (DE3) pLysS NHP1flVHfW6ldHnvckBie3OjeR?= MV[xNFAhdWmwcx?= MV3Jcohq[mm2aX;uJI9nKE27Y3;iZYN1\XKrdX2gd41m\22jdHnzJGd6ekJiQWTQZZNmKGGldHn2bZR6KGW6cILld5Nm\CCrbjDFd4Np\XKrY3jpZUBkd2yrIFLMNlEhMESHMzmgdGx6e1NiY3XscJMh[W[2ZYKgNVAxKG2rboOgZpkhcW6xcnfhcolkKHCqb4PwbIF1\SC{ZXzlZZNmKGSndHXjeIlwdiCkYYPl[EBu[WyjY3jpeIUh\3KnZX6gdoVi\2WwdDDhd5NigSxiSVO1NF0xNjF6zszN MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThyMUG1NUc,OjV6MEGxOVE9N2F-
BL21 (DE3) pLysS NV\TVodWTnWwY4Tpc44h[XO|YYm= M3vGc|ExOCCvaX7z NEjs[G9KdmirYnn0bY9vKG:oIF35Z49j[WO2ZYLpeY0he22nZ33heIl{KESQQTDnfZJie2ViQjDlfJBz\XO|ZXSgbY4hTXOlaHXybYNpcWFiY3;sbUBDVDJzIDjESVMqKHCOeYPTJINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiCDVGDhd4Uh[WO2aY\peJkhcW6ldXLheIVlKG[xcjCxNFAhdWmwczDifUBqdm:{Z3HubYMheGixc4DoZZRmKGSndHXjeIlwdiCjc4PhfUwhUUN3ME2wMlE5|ryP NX\OWY9FRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[zNVgxPTRpPkK2N|E5ODV2PD;hQi=>
BL21 (DE3) pLysS MWLGeY5kfGmxbjDhd5NigQ>? NIfzV2cyOjBibXnudy=> MUPJcohq[mm2aX;uJI9nKE27Y3;iZYN1\XKrdX2gd41m\22jdHnzJFE2PSB4SHnzMZRi\2enZDDEUmEh\3m{YYPlJGIh[2G2YXz5eIlkKGSxbXHpckBCXFCjc3WgZYN1cX[rdImg[ZhxemW|c3XkJIlvKEW|Y3jldolkcGmjIHPvcIkhSkx{MTCoSGU{MSCyTInzV{Bk\WyuczDhd5Nme3OnZDDhd{Bqdm:{Z3HubYMheGixc4DoZZRmKHKnbHXhd4Uh[W[2ZYKgNVIxKG2rboOgbY4heHKnc3XuZ4Uhd2ZiQWTQJIJ6KG2jbHHjbIl1\SCpcnXlckBlgWViYnHz[YQtKEmFNUC9NE4xPDcQvF2= M3;0eVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5M{exPVI2Lz5{N{O3NVkzPTxxYU6=

... Click to View More Cell Line Experimental Data

Protocol

Solubility (25°C)

In vitro DMSO 100 mg/mL (157.57 mM)
Water 100 mg/mL (157.57 mM)
Ethanol ''100 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 634.61
Formula

C31H35N2O11.Na

CAS No. 1476-53-5
Storage powder
in solvent
Synonyms Albamycin, Cathomycin
Smiles CC1=C(C=CC2=C1OC(=O)C(=C2O)NC(=O)C3=CC(=C(C=C3)[O-])CC=C(C)C)OC4C(C(C(C(O4)(C)C)OC)OC(=O)N)O.[Na+]

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field
Tags: buy Novobiocin Sodium (NSC 2382) | Novobiocin Sodium (NSC 2382) supplier | purchase Novobiocin Sodium (NSC 2382) | Novobiocin Sodium (NSC 2382) cost | Novobiocin Sodium (NSC 2382) manufacturer | order Novobiocin Sodium (NSC 2382) | Novobiocin Sodium (NSC 2382) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID